Tumor tissues exhibited substantial upregulation of TFF1, UBE2C, ITPKA, and IGFBP3, alongside concurrent downregulation of SELENBP1 and SLC34A2, relative to matched normal samples. The gene discussed is SLC34A2; the disease is neoplasm.